NCT07079514

Brief Summary

The goal of this triple blinded randomized control trial is to compare the effect of magnesium sulphate on the hemodynamic response during pneumoperitoneum creation, along with its impact on postoperative pain, opioid consumption, and post operative nausea vomiting (PONV) in ASA I to III patients undergoing laparoscopic cholecystectomy The main question\[s\] it aims to answer is whether the agent Magnesium Sulphate will blunt the increase in the hemodynamic response during peritoneal insufflation, and will it decrease post operative opioids consumption and prevent nausea vomiting in patients undergoing laparoscopic surgeries. 30 were given placebo and 30 were introduced with magnesium sulphate (3mg) 5 mins before insufflation. The hemodynamic such as, mean arterial pressure (MAP,) systolic (SBP) and diastolic blood pressures (DBP), heart rate (HR) were recorded pre operatively and intraoperatively with intervals of 5mins. Pain score was recorded by VAS scaling and post operative nausea vomiting (PONV) with Yes and No in post operative anesthesia unit (PACU) period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jan 2025

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 2, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
Last Updated

July 23, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

July 2, 2025

Last Update Submit

July 22, 2025

Conditions

Keywords

PneumoperitoneumHemodynamicsMagnesium SulfatePainPONV

Outcome Measures

Primary Outcomes (2)

  • Changes in Mean arterial pressures (MAP), Systolic blood pressures (SBP), Diastolic blood pressures (DBP)

    Laparoscopic surgeries, such as cholecystectomy, require CO₂ insufflation to create pneumoperitoneum, which leads to increased sympathetic activity, elevated blood pressure

    6 months

  • Changes in Heart Rate (HR)

    Laparoscopic surgeries, such as cholecystectomy, require CO₂ insufflation to create pneumoperitoneum

    6 months

Secondary Outcomes (1)

  • Pain Scores on the Visual Analog SCALE

    6 months

Other Outcomes (1)

  • YES/NO questionnaire for Post operative nausea vomiting

    6 months

Study Arms (2)

group A

PLACEBO COMPARATOR

100ml normal saline is used as placebo

Drug: Placebo

groupB

ACTIVE COMPARATOR

3g magnesium sulphate

Drug: Magnesium

Interventions

normal saline in 100ml piggy bag

group A

Magnesium Sulphate will be given as doses of 20-50mg/kg in 2 -3 minutes. In order to standardize the dose in every patient we will be using 3g

Also known as: MgSo4, Magnesium sulphate
groupB

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 85
  • Gender: Male /Female
  • ASA status I/II/III
  • Patients undergoing elective Laparoscopic cholecystectomy

You may not qualify if:

  • Known Hypermagnesemia
  • Known allergy to Magnesium
  • Any degree of Heart Block
  • Patients on Calcium Channel Blockers
  • Known CKD/AKI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr Ziauddin Hospital

Karachi, Sindh, 75600, Pakistan

Location

Related Publications (11)

  • Shafiq T, Rana MA, Nisar A. Comparison of Hemodynamic Response after Pneumoperitoneum with Versus without Pre-Emptive Magnesium Sulphate in Patients Undergoing Laparoscopic Cholecystectomy. Pakistan Journal of Medical & Health Sciences. 2022 Apr 12;16(03):267

    RESULT
  • Maya G, Ramya N, Anzar S, et al. Effect of magnesium sulfate in attenuating arterial blood pressure in elective laparoscopic abdominal surgeries. J. Evolution Med. Dent. Sci. 2017;6(33):2680-2683, DOI: 10.14260/Jemds/2017/578

    RESULT
  • Zareen A, Gardazi SFA, Anwar MH, Zaheer J. Effects of IV Magnesium Sulphate on Hemodynamic Response to Pneumoperitoneum in Laparoscopic Cholecystectomy; A randomized control. Ann Pak Inst Med Sci. 2021; 17(2):82-85. doi. 10.48036/apims.v17i2.539

    RESULT
  • Murumu DP, Mishra M, Singh AK, Mathur SK. Effect of Magnesium Sulphate on Intra Operative Anesthetic Requirements and Post Operative Analgesia in Plastic Surgery Patients. Int J Anesth Res. 2021 Nov 29;9(03):662-7.

    RESULT
  • Tramer MR, Glynn CJ. An evaluation of a single dose of magnesium to supplement analgesia after ambulatory surgery: randomized controlled trial. Anesth Analg. 2007 Jun;104(6):1374-9, table of contents. doi: 10.1213/01.ane.0000263416.14948.dc.

  • Paul S, Biswas P, Bhattacharjee DP, Sengupta J. Effects of magnesium sulfate on hemodynamic response to carbon dioxide pneumoperitoneum in patients undergoing laparoscopic cholecystectomy. Anesth Essays Res. 2013 May-Aug;7(2):228-31. doi: 10.4103/0259-1162.118970.

  • Jee D, Lee D, Yun S, Lee C. Magnesium sulphate attenuates arterial pressure increase during laparoscopic cholecystectomy. Br J Anaesth. 2009 Oct;103(4):484-9. doi: 10.1093/bja/aep196. Epub 2009 Jul 17.

  • Do SH. Magnesium: a versatile drug for anesthesiologists. Korean J Anesthesiol. 2013 Jul;65(1):4-8. doi: 10.4097/kjae.2013.65.1.4. Epub 2013 Jul 19.

  • Tripathi DC, Shah KS, Dubey SR, Doshi SM, Raval PV. Hemodynamic stress response during laparoscopic cholecystectomy: Effect of two different doses of intravenous clonidine premedication. J Anaesthesiol Clin Pharmacol. 2011 Oct;27(4):475-80. doi: 10.4103/0970-9185.86586.

  • Tan W, Qian DC, Zheng MM, Lu X, Han Y, Qi DY. Effects of different doses of magnesium sulfate on pneumoperitoneum-related hemodynamic changes in patients undergoing gastrointestinal laparoscopy: a randomized, double-blind, controlled trial. BMC Anesthesiol. 2019 Dec 20;19(1):237. doi: 10.1186/s12871-019-0886-4.

  • El Mourad MB, Arafa SK. Effect of intravenous versus intraperitoneal magnesium sulfate on hemodynamic parameters and postoperative analgesia during laparoscopic sleeve gastrectomy-A prospective randomized study. J Anaesthesiol Clin Pharmacol. 2019 Apr-Jun;35(2):242-247. doi: 10.4103/joacp.JOACP_208_18.

Related Links

MeSH Terms

Conditions

PneumoperitoneumPainPostoperative Nausea and Vomiting

Interventions

MagnesiumMagnesium Sulfate

Condition Hierarchy (Ancestors)

Peritoneal DiseasesDigestive System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesNauseaSigns and Symptoms, DigestiveVomiting

Intervention Hierarchy (Ancestors)

Metals, Alkaline EarthElementsInorganic ChemicalsMetals, LightMetalsMagnesium CompoundsSulfatesSulfuric AcidsSulfur AcidsSulfur Compounds

Study Officials

  • Dr Asma A Salam, MBBS, FCPS

    Dr Ziauddin Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2025

First Posted

July 23, 2025

Study Start

January 6, 2025

Primary Completion

April 21, 2025

Study Completion

April 21, 2025

Last Updated

July 23, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

written consent, demographics, co-morbids, hemodynamic parameters of each patients. duration of surgery, total anesthesia duration, time for which pneumoperitoneum was created.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
6 months

Locations